Term ended Jul 11, 2026 · High confidence
20-year base term ends Jul 25, 2028
Held by Alcon Inc.
Filed May 9, 2014 as application 14/273,895 · Granted Aug 4, 2015
Base term, 20 years from filing · capped by a resolved terminal disclaimer
Today
Term ended Jul 11, 2026
2008
2028
Clock starts
Jul 25, 2008
Jul 25, 2008
Term ended
Jul 11, 2026
Jul 11, 2026
Granted
Aug 4, 2015
Aug 4, 2015
base term
after the term ends
fee events
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 8,450,344.
2 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
11
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jul 25, 2008, when application 12/180,259, the earliest non-provisional in its chain, was filed (this one was filed May 9, 2014) | Jul 25, 2028 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 8,450,344) | capped to Jul 11, 2026 | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 2 maintenance fees paid | term ended | High confidence |
| Computed term end | The steps above, in order | Jul 11, 2026 | High confidence |
This family
| US 8,450,344 | Term ended Jul 2026 | Jul 2026 |
| Application PCT/US2009/051569 | PCT application no patent term | no patent term |
| US 8,759,388 | In force no later than Jul 2028 | no later than Jul 2028 |
| US 9,096,569 | this patent Jul 2026 | Jul 2026 |
| US 9,512,101 | Term ended Jul 2026 | Jul 2026 |
| US 9,884,840 | Term ended Jul 2026 | Jul 2026 |
| US 10,112,920 | Term ended Jul 2026 | Jul 2026 |
| US 10,532,993 | Term ended Jul 2026 | Jul 2026 |
8 of 11 applications in this family shown, earliest filings first. Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| May 9, 2014 Reel 32859, frame 825 | Delong, Mitchell A.; Sturdivant, Jill Marie; Royalty, Susan M. | Aerie Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Sep 11, 2014 Reel 33726, frame 43 | Aerie Pharmaceuticals, Inc. | Deerfield Management Company, L.P., as Agent; Deerfield Partners, L.p.; Deerfield International Master Fund, L.P.; Deerfield Private Design Fund III, L.P.; Deerfield Special Situations Fund, L.P.; Deerfield Special Situations International Master Fund, L.P. | Security Interest |
| Sep 11, 2014 reel/frame not recorded | Aerie Pharmaceuticals, Inc. | Deerfield Management Company, L.P., as Agent | Security Interest |
| Sep 11, 2014 reel/frame not recorded | Aerie Pharmaceuticals, Inc. | Deerfield Partners, L.p. | Security Interest |
| Sep 11, 2014 reel/frame not recorded | Aerie Pharmaceuticals, Inc. | Deerfield International Master Fund, L.P. | Security Interest |
| Sep 11, 2014 reel/frame not recorded | Aerie Pharmaceuticals, Inc. | Deerfield Private Design Fund III, L.P. | Security Interest |
| Sep 11, 2014 reel/frame not recorded | Aerie Pharmaceuticals, Inc. | Deerfield Special Situations Fund, L.P. | Security Interest |
| Sep 11, 2014 reel/frame not recorded | Aerie Pharmaceuticals, Inc. | Deerfield Special Situations International Master Fund, L.P. | Security Interest |
| Mar 27, 2017 Reel 41754, frame 369 | Aerie Pharmaceuticals, Inc. | Aerie Distribution, Inc. | Assignment of Assignor's Interest |
| Mar 27, 2017 Reel 41754, frame 402 | Aerie Distribution, Inc. | Aerie Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Jul 23, 2018 Reel 46431, frame 500 | Deerfield Partners, L.p.; Deerfield Private Design Fund III, L.P.; Deerfield Special Situations Fund, L.P.; Deerfield Management Company, L.p. | Aerie Distribution, Inc. | Release of Security Interest |
| Jul 23, 2018 Reel 46431, frame 600 | Deerfield Partners, L.p.; Deerfield Private Design Fund III, L.P.; Deerfield Special Situations Fund, L.P.; Deerfield Management Company, L.p. | Aerie Pharmaceuticals, Inc. | Release of Security Interest |
| Jul 23, 2018 Reel 46432, frame 307 | Aerie Pharmaceuticals, Inc. | Deerfield Private Design Fund III, L.P. | Security Interest |
| Sep 5, 2019 Reel 50276, frame 807 | Deerfield Private Design Fund III, L.P. | Aerie Pharmaceuticals, Inc. | Release of Security Interest |
| Jun 24, 2024 Reel 67822, frame 168 | Aerie Pharmaceuticals, Inc. | Alcon Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
Disclaimer cap
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 8,450,344.
Citations
40
later US patents cite this one
That is top 25% of utility patents granted in 2015 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.